InvestorsHub Logo

HyGro

02/18/22 12:42 PM

#204028 RE: Bill_ENG #204018

LL is owned by Progenics and Abbvie. Welch just get the sublicense that is likely not transferable without Progenics and Abbvie's approval. Either way, Welch doesn't want IP, he wants to flip the 15 million warrants as fast as he can and pocket ~$4.5 million in cash from shareholders. Nice work for a few months investment.